Author

Ziren Wang

Rutgers New Jersey Medical School

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 2 Research Focus:cell signaling & trafficking· 2 Approach:experimental assay· 2 Research Focus:cell type annotation· 1 Research Focus:development & morphogenesis· 1 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1

Frequent Co-Authors

Ahmed AquibiD· 2 shared Alok Kumar ChoudharyiD· 2 shared Christopher VarsanyiiD· 2 shared David C. CalianeseiD· 2 shared Rachael Pulica· 2 shared Sergei V. KotenkoiD· 2 shared Trevor FrederickiD· 2 shared Varsha GadiyariD· 2 shared

Activity by Year

2025-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Ahmed AquibORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Phospholipid Scramblases TMEM16F and Xkr8 regulate distinct features of Phosphatidylserine (PS) externalization and immune regulation in the tumor microenvironment to regulate tumor growth

Varsha Gadiyar, Rachael Pulica, Ahmed Aquib, James A. Tranos, Christopher Varsanyi, Trevor Frederick, Ziren Wang, Luis Fernandez Almansa, Lawrence D. Gaspers, Mariana S. De Lorenzo, Sergei V. Kotenko, Sushil Tripathi, Roger W. Howell, Alok Kumar Choudhary, David C. Calianese, Raymond B. Birge

This study shows that Xkr8 and TMEM16F regulate distinct PS externalization mechanisms in the tumor microenvironment, influencing immune evasion and tumor growth.

Cell Death Discovery · Nov 6, 2025Peer-reviewedCancer Biology

Phosphatidylserine (PS)-targeting chimeric Interferon (IFN) fusion proteins for anti-tumor applications

Varsha Gadiyar, Viralkumar Davra, Rachael Pulica, Trevor Frederick, Christopher Varsanyi, Ahmed Aquib, Ziren Wang, Smirnov Sv, Samhita Bapat, David C. Calianese, Alok Kumar Choudhary, Sergei V. Kotenko, Raymond B. Birge

This paper develops PS-targeting chimeric IFN fusion proteins that enhance anti-tumor activities by combining IFN-β and IFN-λ with the PS-binding Gas6 domain.

bioRxiv · Jan 24, 2025 · PreprintCancer Biology